Less Ads, More Data, More Tools Register for FREE

Pin to quick picksIdox Group Regulatory News (IDOX)

  • There is currently no data for IDOX

Replacement: Total Voting Rights

24 Apr 2024 07:00

RNS Number : 7691L
IDOX PLC
24 April 2024
 

24 April 2024

Idox plc

("Idox" or "Group" or "Company")

Correction - Exercise of Share Options and Total Voting Rights

The following amendment has been made to the "Exercise of Share Options & Total Voting Rights" announcement released 17 April 2024 at 12.43pm under RNS No. 0060L

The original announcement incorrectly stated that the figure to be used for both the total number of ordinary shares in issue following Admission and the total number of ordinary shares with voting rights in the Company was 457,771,879. The correct figure to be used for the total number of ordinary shares in issue following Admission will be 459,377,981. The correct figure to be used for the total number of ordinary shares with voting rights in the Company will be 459,377,981.

All other details remain unchanged. The full amended text is shown below.

Idox plc (AIM: IDOX) a leading supplier of specialist information management software and geospatial data solutions to the public and asset-intensive sectors, announces that it has issued 77,000 new ordinary shares of 1 pence each in the Company ("Ordinary Shares") pursuant to an exercise of options by employees under its Idox plc Long Term Incentive Plans.

An application has been made for the 77,000 new Ordinary Shares to be admitted to trading on AIM ("Admission"). It is expected that Admission will occur at 8.00 a.m. on or around 22 April 2024.

The Company holds no ordinary shares in treasury. The total number of ordinary shares in issue following Admission will be 459,377,981. Therefore, the total number of ordinary shares with voting rights in the Company will be 459,377,981.

The above figure of 459,377,981 may be used by shareholders as the denominator for the calculations by which they will determine if they are required to notify their interest in, or a change to their interest in, the Company under the FCA's Disclosure and Transparency Rules.

-Ends-

For further information please contact:

Idox plc

+44 (0) 870 333 7101

Chris Stone, Non-Executive Chairman

investorrelations@idoxgroup.com

David Meaden, Chief Executive

 

Anoop Kang, Chief Financial Officer

 

 

Peel Hunt LLP (NOMAD and Broker)

+44 (0) 20 7418 8900

Paul Gillam

 

Adam Telling

 

 

MHP

+ 44 (0) 20 3128 8100

Reg Hoare

 idox@mhpgroup.com

Ollie Hoare

Matthew Taylor

 

About Idox plc

For more information see www.idoxplc.com @Idoxgroup

 

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
TVRIJMPTMTITBRI
Date   Source Headline
18th Feb 202612:00 pmRNSForm 8.5 (EPT/RI) Idox PLC
18th Feb 202611:06 amRNSForm 8.3 - Idox plc
18th Feb 202610:11 amGNWForm 8.3 - [IDOX PLC - 17 02 2026] - (CGWL)
17th Feb 20268:55 amGNWForm 8.3 - [IDOX PLC - 16 02 2026] - (CGWL)
17th Feb 20267:00 amRNSFY25 Results
16th Feb 202612:00 pmRNSForm 8.5 (EPT/RI) Idox PLC
16th Feb 20269:19 amGNWForm 8.3 - [IDOX PLC - 13 02 2026] - (CGWL)
13th Feb 20268:49 amGNWForm 8.3 - [IDOX PLC - 12 02 2026] - (CGWL)
13th Feb 20267:00 amRNSAcceptance Level Update
12th Feb 20263:11 pmRNSForm 8.3 - IDOX PLC
12th Feb 20269:50 amGNWForm 8.3 - [IDOX PLC - 11 02 2026] - (CGWL)
11th Feb 20263:07 pmRNSForm 8.3 - IDOX PLC
11th Feb 20263:00 pmBUSForm 8.3
11th Feb 20261:24 pmBUSForm 8.3
11th Feb 202612:00 pmRNSForm 8.5 (EPT/RI) Idox PLC
11th Feb 20269:42 amGNWForm 8.3 - [IDOX PLC - 10 02 2026] - (CGWL)
10th Feb 20263:25 pmRNSForm 8.3 - Idox plc
10th Feb 20263:09 pmRNSForm 8.3 - IDOX PLC
10th Feb 202611:58 amBUSForm 8.3
10th Feb 20267:00 amRNSUpdate on Letters of Intent
9th Feb 20264:47 pmRNSHolding(s) in Company
9th Feb 20263:27 pmRNSForm 8.3 - Idox PLC
9th Feb 20263:25 pmRNSForm 8.3 - Idox plc
9th Feb 20263:10 pmRNSForm 8.3 IDOX PLC
9th Feb 20263:09 pmRNSForm 8.3 - IDOX PLC
9th Feb 20263:00 pmBUSForm 8.3
9th Feb 20262:57 pmBUSForm 8.3 - IDOX plc - Octopus Investments
9th Feb 20262:57 pmGNWForm 8.3 - IDOX plc - Octopus Investments
9th Feb 20261:55 pmRNSForm 8.3 - Idox plc
9th Feb 202612:34 pmRNSForm 8.3 - IDOX PLC
9th Feb 202612:00 pmRNSForm 8.5 (EPT/RI) Idox PLC
9th Feb 202611:54 amBUSForm 8.3
9th Feb 20269:42 amGNWForm 8.3 - [IDOX PLC - 06 02 2026] - (CGWL)
6th Feb 20261:53 pmGNWForm 8.3 - IDOX plc - Octopus Investments
6th Feb 202612:00 pmRNSForm 8.5 (EPT/RI) Idox PLC
6th Feb 20269:06 amGNWForm 8.3 - [IDOX PLC - 05 02 2026] - (CGWL)
6th Feb 20267:00 amRNSDay 21 Acceptance Level Update
6th Feb 20267:00 amRNSUpdate on Letters of Intent
5th Feb 20263:25 pmRNSForm 8.3 - IDOX PLC
5th Feb 20263:25 pmRNSForm 8.3 - Idox plc
5th Feb 20262:45 pmGNWForm 8.3 - IDOX plc - Octopus Investments
5th Feb 20261:20 pmRNSForm 8.3 - IDOX PLC
5th Feb 202612:51 pmRNSForm 8.3 - Idox plc
5th Feb 202612:00 pmRNSForm 8.5 (EPT/RI) Idox PLC
5th Feb 202610:53 amBUSForm 8.3
4th Feb 20263:23 pmRNSForm 8.3 - IDOX PLC
4th Feb 202612:34 pmGNWForm 8.3 - IDOX plc - Octopus Investments
4th Feb 202612:00 pmRNSForm 8.5 (EPT/RI) Idox PLC
4th Feb 202611:15 amBUSForm 8.3
3rd Feb 20261:09 pmGNWForm 8.3 - IDOX plc - Octopus Investments

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.